Applications of the Phytomedicine Echinacea Purpurea (Purple Coneflower) in Infectious Diseases

Overview

Journal J Biomed Biotechnol

Specialty Biology

Date 2011 Dec 2

PMID 22131823

Citations 34

Authors

James B Hudson

Affiliations

Soon will be listed here.

Abstract

Extracts of Echinacea purpurea (EP, purple coneflower) have been used traditionally in North America for the treatment of various types of infections and wounds, and they have become very popular herbal medicines globally. Recent studies have revealed that certain standardized preparations contain potent and selective antiviral and antimicrobial activities. In addition, they display multiple immune-modulatory activities, comprising stimulation of certain immune functions such as phagocytic activity of macrophages and suppression of the proinflammatory responses of epithelial cells to viruses and bacteria, which are manifested as alterations in secretion of various cytokines and chemokines. These immune modulations result from upregulation or downregulation of the relevant genes and their transcription factors. All these bioactivities can be demonstrated at noncytotoxic concentrations of extract and appear to be due to multiple components rather than the individual chemical compounds that characterize Echinacea extracts. Potential applications of the bioactive extracts may go beyond their traditional uses.

Citing Articles

Herbal and Dietary Supplements as Adjunctive Treatment for Mild SARS-CoV-2 Infection in Italy.

Licata A, Seidita A, Como S, de Carlo G, Cammilleri M, Bonica R Nutrients. 2025; 17(2).

PMID: 39861359 PMC: 11767322. DOI: 10.3390/nu17020230.

Phytochemistry, Mechanisms, and Preclinical Studies of Echinacea Extracts in Modulating Immune Responses to Bacterial and Viral Infections: A Comprehensive Review.

Ahmadi F Antibiotics (Basel). 2024; 13(10).

PMID: 39452214 PMC: 11504277. DOI: 10.3390/antibiotics13100947.

Analytical Assessment of the Antioxidant Properties of the Coneflower ( L. Moench) Grown with Various Mulch Materials.

Adebimpe Ojo C, Dziadek K, Sadowska U, Skoczylas J, Kopec A Molecules. 2024; 29(5).

PMID: 38474483 PMC: 10934613. DOI: 10.3390/molecules29050971.

Polyphenolic Characterization and Anti-Inflammatory Effect of In Vitro Digested Extracts of L. Plant Parts in an Inflammatory Model of Human Colon Cells.

Avila-Galvez M, Gimenez-Bastida J, Karadeniz B, Romero-Reyes S, Espin J, Pelvan E Int J Mol Sci. 2024; 25(3).

PMID: 38339018 PMC: 10855148. DOI: 10.3390/ijms25031744.

Echinacea purpurea extract intervention for counteracting neurochemical and behavioral changes induced by bifenthrin.

Abdel-Wahhab K, Sayed R, El-Sahra D, Hassan L, Elqattan G, Mannaa F Metab Brain Dis. 2023; 39(1):101-113.

PMID: 38150137 PMC: 10799807. DOI: 10.1007/s11011-023-01303-6.

References

Ishizuka S, Yamaya M, Suzuki T, Takahashi H, Ida S, Sasaki T . Effects of rhinovirus infection on the adherence of Streptococcus pneumoniae to cultured human airway epithelial cells. J Infect Dis. 2003; 188(12):1928-39. DOI: 10.1086/379833. View

Zhang L, Peeples M, Boucher R, Collins P, Pickles R . Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J Virol. 2002; 76(11):5654-66. PMC: 137037. DOI: 10.1128/jvi.76.11.5654-5666.2002. View

Roxas M, Jurenka J . Colds and influenza: a review of diagnosis and conventional, botanical, and nutritional considerations. Altern Med Rev. 2007; 12(1):25-48. View

Canlas J, Hudson J, Sharma M, Nandan D . Echinacea and trypanasomatid parasite interactions: growth-inhibitory and anti-inflammatory effects of Echinacea. Pharm Biol. 2010; 48(9):1047-52. DOI: 10.3109/13880200903483468. View

Wang C, Staniforth V, Chiao M, Hou C, Wu H, Yeh K . Genomics and proteomics of immune modulatory effects of a butanol fraction of echinacea purpurea in human dendritic cells. BMC Genomics. 2008; 9:479. PMC: 2571112. DOI: 10.1186/1471-2164-9-479. View

Aly S, Mohamed M . Echinacea purpurea and Allium sativum as immunostimulants in fish culture using Nile tilapia (Oreochromis niloticus). J Anim Physiol Anim Nutr (Berl). 2010; 94(5):e31-9. DOI: 10.1111/j.1439-0396.2009.00971.x. View

Nicholls J, Butany J, Poon L, Chan K, Beh S, Poutanen S . Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS. PLoS Med. 2005; 3(2):e27. PMC: 1324951. DOI: 10.1371/journal.pmed.0030027. View

Ghezzi P . Role of glutathione in immunity and inflammation in the lung. Int J Gen Med. 2011; 4:105-13. PMC: 3048347. DOI: 10.2147/IJGM.S15618. View

Schoop R, Klein P, Suter A, Johnston S . Echinacea in the prevention of induced rhinovirus colds: a meta-analysis. Clin Ther. 2006; 28(2):174-83. DOI: 10.1016/j.clinthera.2006.02.001. View

10.

Kim S, Kim J, Lee N, Hyun C . Antibacterial and anti-inflammatory effects of Jeju medicinal plants against acne-inducing bacteria. J Gen Appl Microbiol. 2008; 54(2):101-6. DOI: 10.2323/jgam.54.101. View

11.

Bengtson S, Eddleston J, Christiansen S, Zuraw B . Double-stranded RNA increases kinin B1 receptor expression and function in human airway epithelial cells. Int Immunopharmacol. 2007; 7(14):1880-7. DOI: 10.1016/j.intimp.2007.07.002. View

12.

Jefferson T, Di Pietrantonj C, Debalini M, Rivetti A, Demicheli V . Inactivated influenza vaccines: methods, policies, and politics. J Clin Epidemiol. 2009; 62(7):677-86. DOI: 10.1016/j.jclinepi.2008.07.001. View

13.

Nichols W, Peck Campbell A, Boeckh M . Respiratory viruses other than influenza virus: impact and therapeutic advances. Clin Microbiol Rev. 2008; 21(2):274-90, table of contents. PMC: 2292575. DOI: 10.1128/CMR.00045-07. View

14.

Currier N, Miller S . Natural killer cells from aging mice treated with extracts from Echinacea purpurea are quantitatively and functionally rejuvenated. Exp Gerontol. 2000; 35(5):627-39. DOI: 10.1016/s0531-5565(00)00106-6. View

15.

Burns J, Zhao L, Taylor E, Spelman K . The influence of traditional herbal formulas on cytokine activity. Toxicology. 2009; 278(1):140-59. DOI: 10.1016/j.tox.2009.09.020. View

16.

Neumann G, Noda T, Kawaoka Y . Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature. 2009; 459(7249):931-9. PMC: 2873852. DOI: 10.1038/nature08157. View

17.

Sajjan U, Wang Q, Zhao Y, Gruenert D, Hershenson M . Rhinovirus disrupts the barrier function of polarized airway epithelial cells. Am J Respir Crit Care Med. 2008; 178(12):1271-81. PMC: 2599868. DOI: 10.1164/rccm.200801-136OC. View

18.

See H, Wark P . Innate immune response to viral infection of the lungs. Paediatr Respir Rev. 2008; 9(4):243-50. PMC: 7172072. DOI: 10.1016/j.prrv.2008.04.001. View

19.

Allen P . Dietary supplementation with Echinacea and development of immunity to challenge infection with coccidia. Parasitol Res. 2003; 91(1):74-8. DOI: 10.1007/s00436-003-0938-y. View

20.

Ludwig S . Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy. J Antimicrob Chemother. 2009; 64(1):1-4. DOI: 10.1093/jac/dkp161. View